STRATA Skin Sciences (NASDAQ:SSKN) Releases Earnings Results, Misses Expectations By $0.73 EPS

STRATA Skin Sciences (NASDAQ:SSKN) announced its quarterly earnings results on Thursday. The medical device company reported ($1.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by ($0.73), Zacks reports. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 69.33%.

STRATA Skin Sciences Stock Up 1.1 %

SSKN traded up $0.03 during trading on Thursday, reaching $2.64. The stock had a trading volume of 2,388 shares, compared to its average volume of 12,188. The company has a current ratio of 1.13, a quick ratio of 0.94 and a debt-to-equity ratio of 1.62. The company has a market capitalization of $11.01 million, a price-to-earnings ratio of -0.99 and a beta of 1.32. The stock’s 50 day moving average is $2.76 and its two-hundred day moving average is $2.92. STRATA Skin Sciences has a one year low of $2.51 and a one year high of $5.90.

Analyst Ratings Changes

Separately, Maxim Group initiated coverage on STRATA Skin Sciences in a report on Thursday, February 27th. They set a “buy” rating and a $6.00 target price on the stock.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.